Cancer Currents: An NCI Cancer Research Blog
A blog featuring news and research updates from the National Cancer Institute. Learn more about Cancer Currents.
-
The Exceptional Responders Initiative: Welcoming More CasesThe initiative is studying tissue, clinical, and genomic data from patients with cancer who have had dramatic and long-lasting responses to standard and experimental treatments that were not seen in similar patients who received the same treatment.
-
Who Will Respond to PD-1 Inhibition? Study Provides CluesA new study shows that specific DNA changes in a tumor may help determine which patients are most likely to respond to treatment with PD-1 inhibitors
-
FDA Approves Panobinostat for Some Patients with Multiple MyelomaThe FDA granted accelerated approval of panobinostat for the treatment of multiple myeloma that has progressed after at least two prior standard therapies.
-
DNA "Minicircles" Could Improve Cancer Detection, Study SuggestsInjecting customized DNA “rings” into tumor-bearing mice caused the tumor cells to release a biomarker that can be detected with a simple blood test.
-
Smoking’s Disease Burden: Worse than Previously Thought?According to a new study, smoking may be responsible for far more deaths each year than previously thought.
-
Treatment Helps Preserve Fertility for Some Women with Breast CancerIn a large clinical trial, giving a hormone-suppressing drug helped some younger women with breast cancer get pregnant after completing cancer treatment.
-
Conference Report: Pursuing Progress Against HIV-Related CancersAt the recent annual Conference on Retroviruses and Opportunistic Infections, several NCI researchers and NCI-funded investigators presented important new findings on HIV-related cancers.
-
FDA Approves Lenvatinib for Radioactive Iodine-Refractory Thyroid CancerThe FDA has approved lenvatinib (Lenvima) to treat some patients with the most common type of thyroid cancer.
-
Genetic Studies Yield Clues to Treatment-Related Side Effects in Children with CancerResearchers have identified genetic variations in children with brain cancer that increased their risk of rapid hearing loss after treatment.
-
New from NCI: Resources, Tools, and NewsNCI is constantly publishing new information on its websites, so periodically we provide updates on new content of interest to the cancer community.
-
"Flipping the Switch": An Interview with Dr. Mark Gilbert, Chief of NIH’s Neuro-Oncology BranchNCI's Dr. Mark Gilbert discusses new developments in neuro-oncology and the priorities of the Neuro-Oncology Branch.
-
Exposure to Secondhand Smoke Plummets, but Disparities PersistSecond-hand smoke exposure has fallen by 50 percent since 1999, a new study finds, but millions are still routinely exposed to secondhand smoke.
-
FDA Grants Palbociclib Accelerated Approval for Advanced Breast CancerPalbociclib (Ibrance) is approved to be used in combination with letrozole (Femara) to treat postmenopausal women with metastatic breast cancer.
-
Medicare to Cover Annual Lung Cancer Screening for Some BeneficiariesFor the first time, Medicare will cover the costs of lung cancer screening for some beneficiaries, the Centers for Medicare and Medicaid Services (CMS) announced on February 5.
-
Genome Study Yields Clues to Head and Neck CancersResearchers have surveyed the genetic changes in nearly 300 head and neck cancers, revealing some previously unknown alterations that may play a role in the disease, including in patients whose cancer is associated with the human papillomavirus (HPV).
-
Precision Medicine Initiative® and Cancer ResearchUnder the Precision Medicine Initiative, NCI is working to accelerate the pace of research that will help identify which treatments work best for which patients.
-
A Good Year: FDA Approved Nine New Cancer Drugs in 2014In 2014, the Food and Drug Administration (FDA) approved 41 drugs that had not been approved previously for any indication, the most in nearly 20 years. Of these 41 novel drugs, 9 were approved for the treatment of cancer or cancer-related conditions.
-
Bacterial Biofilms Provide Clues into Colorectal Cancer RiskA new study suggests that dense bacterial communities called biofilms may promote the development of some colorectal cancers.
-
Analyzing the Gut Microbiome to Help Detect Colorectal CancerNew research suggests that identifying specific changes in the gut microbiome could potentially help screen patients for colorectal cancer.
-
Report Offers Comprehensive Look at Global Smokeless Tobacco UseThe first report of its kind finds that more than 300 million people worldwide use smokeless tobacco products and that they are linked to a number of cancers.